首页> 美国卫生研究院文献>Bioscience Reports >MiR-34b inhibits the proliferation and promotes apoptosis in colon cancer cells by targeting Wnt/β-catenin signaling pathway
【2h】

MiR-34b inhibits the proliferation and promotes apoptosis in colon cancer cells by targeting Wnt/β-catenin signaling pathway

机译:MiR-34b通过靶向Wnt /β-catenin信号通路抑制结肠癌细胞的增殖并促进其凋亡

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Colon cancer is one of the leading cause of cancer deaths that is severely threatening human health. Several microRNAs (miRNAs) have been found to be associated with the tumor genesis of colon cancer. The present study determined the expression of miR-34b in patients with colon cancer and studied the molecular mechanism of miR-34b in the proliferation and apoptosis of human colon cancer Caco-2 cells . In colon cancer patients, the expression of miR-34b was decreased in tumor tissues when compared with the adjacent non-tumor tissues. Furthermore, overexpression of miR-34b inhibited proliferation, migration and invasion, while promoted apoptosis in colon cancer cells. The online bioinformatics sites predicted possible regulatory genes of miR-34b and luciferase reporter assay verify that β-catenin was a direct target of miR-34b. Furthermore, miR-34b overexpression significantly decreased the expression of genes associated with Wnt/β-catenin signaling pathway. In conclusion, our results suggest that miR-34b may inhibit migration and invasion of human colon cancer cells by regulating Wnt/β-catenin signaling and miR-34b may be a key target for the treatment and diagnosis of colon cancer.
机译:结肠癌是导致严重威胁人类健康的癌症死亡的主要原因之一。已经发现几种微小RNA(miRNA)与结肠癌的肿瘤发生有关。本研究确定了miR-34b在结肠癌患者中的表达,并研究了miR-34b在人结肠癌Caco-2细胞增殖和凋亡中的分子机制。在结肠癌患者中,与邻近的非肿瘤组织相比,miR-34b在肿瘤组织中的表达降低。此外,miR-34b的过表达抑制结肠癌细胞的增殖,迁移和侵袭,同时促进细胞凋亡。在线生物信息学站点预测了miR-34b的可能调控基因,荧光素酶报告基因检测证实β-catenin是miR-34b的直接靶标。此外,miR-34b过表达显着降低了与Wnt /β-catenin信号通路相关的基因的表达。总之,我们的结果表明,miR-34b可能通过调节Wnt /β-catenin信号传导而抑制人结肠癌细胞的迁移和侵袭,而miR-34b可能是治疗和诊断结肠癌的关键靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号